Ranchi News Desk

Release Coating Market Forecasted to Flourish at $225 Million by 2025, at a CAGR of 7.5%

Release Coating Market Forecasted to Flourish at $225 Million by 2025, at a CAGR of 7.5%

Browse 283 market data Tables and 45 Figures spread through 211 Pages and in-depth TOC on “Release Coating Market” Release Coating Market Material (Silicone, Non-Silicone), Formulation(Solvent Based, Solventless, Emulsions), Release

Read Full Article

Lateral Flow Assays Market worth $22.6 billion by 2027

Asia-Pacific is the second largest region along with fastest growing region of lateral flow assays market owing to major investments in rapid testing in this region. Lateral Flow Assays Market

Read Full Article

Label-free Detection Market worth $863 million | MarketsandMarkets

Label Free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chips, Microplates), Software), Technology (Surface Plasmon Resonance), Application (Hit Confirmation, Lead Generation), End User (Pharma, CROs) & Region –

Read Full Article

Calcite Market Surges: A Flourishing Future Unveiled

Browse 105 Market Data Tables and 36 Figures spread through 145 Pages and in-depth TOC on “Calcite Market” Calcite Market by Type (GCC, PCC), Application (Paper, Paints & Coatings, Construction,

Read Full Article

Glioma Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 | AstraZeneca, Pfizer, Bristol-Myers Squibb, Orbus Therapeutics, Hoffman-La-Roche, Incyte Corporation, and others.

DelveInsight’s, “Glioma Pipeline Insight 2023” report provides comprehensive insights about 190+ companies and 130+ pipeline drugs in the Glioma pipeline

Read Full Article

Eczema Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 | LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, AstraZeneca, Kyowa Kirin, and Others

DelveInsight’s, “Eczema Pipeline Insight 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape.

Read Full Article

Colorectal Cancer Pipeline, FDA Approvals, Clinical Trials Development and Companies 2023 | Mirati Therapeutics, Exelixis, Enterome, Arcus Biosciences, AstraZeneca, Novartis Pharmaceuticals and Others

DelveInsight’s, “Colorectal Cancer Pipeline Insight 2023” report provides comprehensive insights about 145+ companies and 150+ pipeline drugs in the Colorectal

Read Full Article

Idiopathic Pulmonary Fibrosis Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 | Novartis, CSL Behring, AstraZeneca, Kadmon Pharmaceuticals, Calliditas Therapeutics, and others

DelveInsight’s, “Idiopathic Pulmonary Fibrosis Pipeline Insight 2023” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic

Read Full Article

Major Depressive Disorder Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 | GH Research, Praxis Precision Medicines, AbbVie, Gedeon Richter, Bristol-Myers Squibb, and others.

DelveInsight’s, “Major Depressive Disorder Pipeline Insight 2023” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the

Read Full Article

Multiple Sclerosis Pipeline, FDA Approvals, Clinical Trials Development and Companies 2023 | Merck Serono, Bristol- Myers Squibb, Sanofi, Genentech, Novartis Pharmaceuticals, AstraZeneca, and others.

DelveInsight’s, “Multiple Sclerosis Pipeline Insight 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple

Read Full Article